Introduction
We have identified a factor, Tome-1, required for wee1 degradation and mitotic entry in Xenopus egg extracts. Progression through the eukaryotic cell cycle requires the coordinated activity of proteolytic triggers and kiTome-1 is a protein that contains an F box motif. Interestingly, it is degraded during the G1 phase of the cell nase cascades (King et al., 1996) . A key regulatory complex essential for coordinating the cell cycle in mitosis cycle in an APC-dependent manner to allow wee1 to accumulate during S phase and reset the CDC25/wee1 is the anaphase promoting complex or APC. The APC is an E3 ligase that mediates transfer of ubiquitin to switch. critical cell cycle regulators such as cyclin B, securin, and geminin, thereby targeting them for destruction by Results the 26S proteasome (Peters, 1999) .
The timing of APC substrate recognition is precisely Tome-1 Is a Novel Substrate of APC CDH1 regulated during the cell cycle. APC only targets subTo identify novel substrates of the G1 active APC, we strates for degradation during mitosis and G1 (Fang et modified an in vitro expression cloning strategy used al., 1998). For the APC to be active at these phases of previously to clone three novel mitotic substrates of the the cell cycle, it must associate with one of two WD40 APC: geminin, vertebrate securin, and Xkid (Funabiki containing proteins, CDC20 or CDH1. CDC20 activates and Murray, 2000; McGarry and Kirschner, 1998; Zou et the APC during mitosis, while CDH1 binds the APC at al., 1999). After in vitro translating pools of Xenopus the end of mitosis and throughout G1. CDC20 levels laevis cDNAs in an 35 S-labeling reticulocyte lysate transdecrease dramatically during G1, since CDC20 itself is a lation system, we incubated the translated products with substrate of the APC when activated by CDH1 (APC
CDH1 )
Xenopus egg extracts in the presence or absence of (Fang et al., 1998; Visintin et al., 1997). recombinant CDH1. Since there is little, if any, expres-APC activity is also positively regulated by phosphorysion of CDH1 in the egg, we were able to use Xenopus lation. For example, phosphorylation of the core APC egg extracts as a source of CDH1-deficient APC (Lorca et al., 1998). After termination of the degradation reactions, SDS-PAGE analysis, and autoradiography, we *Correspondence: marc@hms.harvard.edu identified proteins that were degraded specifically in the when there is the greatest proportion of cells in the G2 or M phases of the cell cycle. By contrast, both cyclin presence of APC
CDH1
. We then isolated the corresponding cDNAs to these proteins through a selection proce-B and Tome-1 levels decreased as the proportion of cells in the G1 phase of the cell cycle increased, sugdure described in Lustig et al. (1997) . We named one of the proteins Tome-1, since we later discovered that it gesting that both proteins are degraded at this time.
A second indication that Tome-1 levels fluctuate functions as a trigger of mitotic entry.
Xenopus Tome-1 is 30% identical to human Tome-1, throughout the cell cycle came when we immunostained CFPAC cells with the anti-Tome-1 antibody. We found contains two N-terminal destruction boxes, and a C-terminal KEN ( Figure 1A) . The presence of a KEN sethat the intensity of the immunofluorescence signal for Tome-1 was greater in mitotic cells than in nonmitotic quence in Tome-1 suggested that Tome-1 is a bona fide substrate of the APC. To test this claim, we asked cells ( Figure 2C ). We also observed that in almost all cells, the endogenous Tome-1 was predominantly cytowhether Tome-1 degradation can be competitively inhibited by adding increasing concentrations of a known solic ( Figure 2C ). Further, when we overexpressed Tome-1 in tissue culture cells, it was exclusively cytosolic. (Fig-APC substrate. As illustrated in Figure 1B , Tome-1 is degraded in a CDH1-dependent manner, but this degraure 2D). dation is inhibited greatly in the presence of the N-terminal region of cyclin B. To test whether degradation Tome-1 Associates with Skp-1 of Tome-1 is proteasome mediated, we performed deg-
The observation that Tome-1 is a cytosolic protein radation reactions in the presence of 100 M of the whose expression is greatest at mitosis indicated that it proteasomal inhibitor MG132 (Lee and Goldberg, 1998).
may have an essential function at this time. We reasoned Under these conditions, which are known to inhibit prothat we could potentially discover the mitotic cellular teasomal activity, no degradation of Tome-1 was obpathway in which Tome-1 functions by identifying Tomeserved, suggesting that active proteasomes are required 1-interacting proteins. We therefore purified Tome-1 for degradation of Tome-1. from nocodazole-arrested XTC cells and assayed assoTo determine if Tome-1 is strictly an APC CDH1 substrate ciated proteins. When these extracts were fractionated or both an APC CDH1 and an APC CDC20 substrate, we asby size exclusion chromatography, we observed that sayed degradation of Tome-1 in mitotic extracts. We Tome-1 elutes as part of a complex with an apparent used a nondegradable version of cyclin B (⌬90) to drive molecular weight of 400 kDa. Tome-1 complexes were interphase extracts into mitosis, thereby activating detected by immunoblot analysis of column fractions APC
CDC20
. We then assayed degradation of Tome-1 in using an anti-Tome-1 antibody ( Figure 3A) . Since a twothese extracts. As illustrated in Figure 1C, complex by combining size exclusion and sucrose denTome-1 is required for its degradation, we mutated each sity gradient profiles (sedimentation coeffiicient of 5S), of these three residues to alanine and determined if the we found a mass of 140 kDa, which is the predicted mutated Tome-1 can be degraded in CDH1-supplemass of a Tome-1, Skp-1, Cul-1 complex. mented extracts. Figure 1B demonstrates that mutation To determine if Tome-1 interacts with Skp-1 in vitro, of the KEN sequence to alanine stabilized Tome-1 in CDH1
we performed an in vitro binding assay with purified supplemented extracts, suggesting that the C-terminal Tome-1 and
35
S-labeled Skp-1. A GST-Tome-1 fusion KEN sequence present in Tome-1 is necessary for recprotein was expressed in E. coli, immobilized on glutaognition by CDH1. By contrast, mutation of the destructhione beads, and subsequently incubated with in vitro tion boxes had no effect on CDH1-dependent degradatranslated Skp-1. After washing away the unbound tion in Xenopus egg extracts (data not shown).
Skp-1, we found that significant binding of Skp-1 was observed to beads containing GST-mTome-1 relative to beads containing only GST ( Figure 3B ). Since most Tome-1 Is a Cytosolic Protein Degraded during G1 Our degradation assays suggested that Tome-1 is a proteins known to associate with Skp-1 are F box proteins, we wondered if Tome-1 contained an F box. Close substrate of APC CDH1 in vitro. To determine if Tome-1 is also degraded in vivo, we assayed Tome-1 protein levels inspection of Tome-1 sequences indicated that a putative F box motif exists in all Tome-1 proteins, suggesting throughout the somatic cell cycle. We arrested HeLa cells at the G1/S transition with a double thymidine that Tome-1 may be a member of the F box family of proteins ( Figure 1A ). To determine if the F box motif is block, released the cells by washing away the thymidine, and then determined the cell cycle profile of these cells necessary for Tome-1 to interact with Skp-1, we engineered versions of Tome-1 lacking putative F boxes and by FACS analysis. We also compared the relative amounts of cyclin B and Tome-1 by Western analysis. tested if they interacted with Skp-1, as judged by the glutathione coprecipitation assay. As shown in Figure  As We confirmed that this region contains the F box, recombinant ⌬N-Tome-1 and injected it into both halves of dividing Xenopus embryos at the two-cell stage. After since a mutated form of Tome-1 lacking critical F box residues did not bind Skp-1. As shown in Figure 3C , several cell divisions, we observed that the embryos injected with ⌬N-Tome-1 had a reduced number of cells mutating two essential F box residues (LP) to alanine reduced the extent to which Tome-1 interacted with relative to uninjected embryos. These data suggested that injection of ⌬N-Tome-1 was affecting cell cycle proSkp-1. Also, less Cul-1 precipitated with the F box mutant of Tome-1 relative to wt Tome-1 ( Figure 3C ). gression, perhaps by inhibiting mitotic entry ( Figure 4A ). To determine whether ⌬N-Tome-1 affected mitotic enAlthough Xenopus Tome-1 does not contain the LP residues found in mouse and human Tome-1, it does try, we examined the effects of adding ⌬N-Tome-1 in vitro in Xenopus extracts. Unfertilized egg extracts are associate with Skp-1 and Cul-1 in vitro. We incubated recombinant Xenopus Tome-1 in extracts isolated from arrested in meiosis by cytostatic factor (CSF) and can be induced to cycle into interphase and then into mitosis SF9 cells expressing an HA-tagged version of Cul-1 and untagged Skp-1. Subsequently, we determined the amount upon calcium addition (Murray, 1991) . Cell cycle progression can be easily monitored in these extracts by of Xenopus Tome-1 associated with anti-HA immunoprecipitates either containing or lacking HA-Cul-1 and observing nuclear formation and nuclear envelope breakdown of added sperm nuclei, the second being a direct Skp-1 by Coomassie staining and LC-MS/MS. As depicted in Figure 3D , Xenopus Tome-1 efficiently interacts measure of mitotic entry. To assay whether ⌬N-Tome-1 affected mitotic entry in Xenopus egg extracts, we with HA-Cul-1 and Skp1, but not with HA beads alone. no effect on the rate of mitotic entry 120 min after release from CSF arrest, as condensed nuclei were readily apparent. By contrast, incubation of the same Xenopus extract with 100 nM ⌬N-Tome-1 mutant markedly inhibited mitotic entry, as the chromatin remained decondensed 120 min after calcium addition ( Figure 4B ).
Since mitotic entry was inhibited when we added ⌬N-Tome-1 to an extract, we wondered if it somehow affected cdk1 activation, a critical step in entering mitosis. Cyclin bound cdk1 can oscillate between an active and inactive pool, with an inhibitory phosphorylation on tyrosine 15. To determine the activity of cdk1, we performed Western blots using a phosphotyrosine-specific anti-cdk1 antibody on samples taken 0, 60, or 120 min after release from CSF arrest. As shown in Figure  4C , addition of buffer had no effect on the extent to which cdk1 was tyrosine phosphorylated. We found that there was no tyrosine phosphorylation on cdk1 at the 0 min time point as expected, since cdk1 was active and there was no detectable inhibitory phosphorylation on tyrosine 15. The amount of tyrosine phosphorylation on cdk1 at the 60 min time point, however, increased substantially as the extract cycled into interphase. As the extract entered mitosis, the amount of tyrosine phosphorylation on cdk1 decreased to the point of undetectability ( Figure 4C) .
In contrast to what we observed above, addition of ⌬N-Tome-1 greatly affected the amount of tyrosine phosphorylation on cdk1 relative to the buffer control. As expected, the amount of tyrosine phosphorylation on cdk1 at the 0 min time point was low and high at the 60 min point. However, tyrosine phosphorylation on cdk1 remained high 120 min after release from CSF, extracts. The consequence of depleting Tome-1 on cdk1 activity was measured by a conventional H1 kinase assay after releasing the extract from CSF arrest with added wild-type and ⌬N versions of Tome-1 to Xenopus mitotic (CSF) egg extracts released with calcium and Ca 2ϩ for 20 min. Figure 5A illustrates that greater than 95% of the endogenous Tome-1 was depleted with Dyvisually examined the chromatin to determine if nuclear formation or nuclear envelope breakdown had occurred nal-beads containing the anti-Tome-1 antibody, while IgG control beads removed little or no Tome-1 from the in each case. As shown in Figure 4B , incubation of these cycling egg extracts with 100 nM wild-type Tome-1 had extracts. Tome-1-depleted extracts supplemented with sperm nuclei entered mitosis much later than mockMichael and Newport (1998) have recently shown that mitotic entry in Xenopus egg extracts requires degradadepleted (IgG-depleted) extracts, suggesting that Tome-1 is required for mitotic entry in Xenopus egg extracts (Figtion of the cdk1 inhibitory tyrosine kinase wee1. Since we observed higher levels of phosphotyrosine on cdk1 ure 5A).
(Y15) in the presence of ⌬N-Tome-1 and since wee-1 is of wee1 degradation on Tome-1 in somatic cells, we one of the kinases that phosphorylates cdk1 at this site, engineered an inducible cell line expressing a dominantwe tested if removal of Tome-1 affected wee1 degradanegative version of mouse Tome-1 lacking the F box tion. CSF extracts were incubated with either antimotif (⌬N-Tome-1). As indicated in Figure 5E , inducing Tome-1 antibody or control IgG antibody coupled to expression of ⌬N-Tome-1 increased the amount of wee1 protein A-Dynal beads. After incubation for 2 hr at 4ЊC, present in 293 cells arrested with nocodazole by at least we added sperm nuclei and assayed the extracts for 10-fold. We concluded from this experiment that exprestheir capacity to degrade 35 S-labeled in vitro translated sion of this mutant protein affected the wee1 degradawee1 after first releasing the extract from CSF arrest tion rate, rather than wee1 expression, since we assayed with Ca 2ϩ for 20 min. As shown in Figure 5B , the initial wee1 levels in nocodazole-arrested cells at a time when rate of wee1 degradation is inhibited 4-to 5-fold when wee1 expression is not transcriptionally regulated (KaTome-1 is immunodepleted from Xenopus egg extracts. wasaki et al., 2001). Therefore, the expression of a domiAbout half the degradation rate is recovered when nant-negative form of Tome-1 in somatic cells inhibits Tome-1 is added back to the extract, indicating that wee1 degradation. Tome-1 is required for wee1 degradation. As a control, We also find that removing Tome-1 from somatic cells we assayed degradation of another SCF substrate, inhibits wee1 degradation. We reduced Tome-1 expres-␤-catenin, in the same extract. As depicted in Figure 5C , sion by transfecting 293 cells with small interfering RNA degradation of ␤-catenin was unaffected when Tome-1 oligomers and subsequently assayed wee1 degradation was immunodepleted from Xenopus egg extracts, sugby pulse-chase analysis of endogenous wee1. As shown gesting that the inability of wee1 to be degraded in in Figure 5F , wee1 degradation occurs in cells transTome-1-depleted extracts is not due to a general inhibifected with an oligomer that does not affect Tome-1 tion of degradation but, rather, a more specific effect expression (Oligo1), but is inhibited in cells transfected on wee1.
with oligomers that affect Tome-1 expresssion (Oligo2
Studies have indicated that that a feedback loop exand Oligo3). ists in which active cdk1 phosphorylates wee1, thereby leading to wee1 inactivation (Mueller et al., 1995). This

Tome-1 Associates with Phospho-Wee1 and Is mitotic phosphorylation of wee1 is easily observed by
Required for Its Ubiquitinylation SDS-PAGE, since there is a substantial reduction of
Since Tome-1 is required for wee1 degradation in both wee1 mobility ("mitotic shift") at this time. Therefore, embryonic and somatic cells, we wondered if it was also wee1 mobility can be used as a measure of whether an required for wee1 ubiquitinylation. To test this, we first extract is in mitosis or interphase. As shown in Figure  isolated interphase Xenopus egg extracts and incubated 5B, wee1 does not shift appreciably in Tome-1-depleted them with sperm nuclei. Subsequently, we added in vitro extracts (some mitotic shifting is observed at the 120 translated wee1, GST-ubiquitin, or a mixture of GSTmin and 150 min time points upon overexposure of the ubiquitin and methyl-ubiquitin, the latter being an effecfilm). By contrast, addition of Tome-1 back to the Tometive inhibitor of polyubiquitinylation. We then compared 1-depleted extract restores wee1 shifting at 60 min, indithe extent of wee1 polyubiquitinylation in the presence cating that this extract entered mitosis. Similarly, the or absence of excess Tome-1 after SDS-PAGE and automock-depleted extract contained mitotically shifted radiography. As can be seen in Figure 6A , including 50 wee1 1 hr after the experiment was initiated, indicating nM Tome-1 in the reaction greatly increased the extent that this extract cycled from interphase into mitosis. of wee1 ubiquitinylation. This observed ubiquitinylation Recent studies have also indicated that wee1 degrawas reduced in the presence of methyl-ubiquitin, dation is accelerated in the presence of nuclei and that thereby demonstrating that we are indeed measuring the nuclear pool of wee1 is particularly sensitive to proubiquitinylation of wee1 as opposed to some other modteolysis (Michael and Newport, 1998). To test if Tomeification. 1 is required for the nuclear-dependent degradation of Our ubiquitinylation studies indicated that Tome-1 is wee1, we checked to see if removing Tome-1 would required for wee1 ubiquitinylation. One conclusion from affect the degradation rate of nuclear wee1. We perthese studies is that Tome-1 may interact with wee1 in formed an experiment similar to the one described in a phosphospecific manner. To determine this, we tested Figure 5B , but this time we measured the levels of wee1 whether Tome-1 could interact with wee1 or a mutant in the nuclear fraction, after sedimenting nuclei through of wee1 in which a serine is changed to alanine at posia sucrose cushion. We first insured that the nuclei retion 38, a site found to be phosphorylated in Xenopus mained intact throughout the experiment by preincubatinterphase extracts ( Figure 6G ; see Experimental Proceing the extract with cycloheximide, which inhibits the dures). We first incubated wee1 or S38A wee1 with insynthesis of cyclin B and mitotic entry, and subseterphase egg extracts supplemented with nuclei and the quently checked nuclear morphology microscopically proteasome inhibitor MG132. Subsequently, we incuafter Ca 2ϩ addition (data not shown). As shown in Figure  bated these extracts with GST-Tome-1 or an unrelated 5D, the nuclear pool of wee1 is completely degraded protein, GST-VCA. We then determined the amount of within 1 hr when Tome-1 is present, but is not substanwee1 or S38A wee1 bound to the GST fusion proteins tially degraded when Tome-1 is depleted from the exby performing a glutathione precipitation assay and pertract.
forming a Western blot for wee1 (lanes 1-3 for wild-type The above observations suggested that Tome-1 is wee1 and lanes 4-6 for S38A wee1). As shown in Figure  required for the nuclear-dependent degradation of wee1 6C, GST-Tome-1 precipitated wild-type wee1 (25% of during an embryonic cell cycle. Studies have also deminput wee1 was pulled down with GST-Tome-1 as oponstrated that wee1 is degraded in the somatic cell cycle (Watanabe et al., 1995) . To examine the dependence posed to 8% precipitated with GST-VCA). By contrast, the S38A mutant showed little interaction with GST-SCF ligases. Both ligases are similar in that they are multisubunit complexes containing ring finger and cullin Tome-1 (2.5% of input wee1 precipitated with GSTTome-1 as compared to 8% precipitated with GST-VCA).
proteins. They differ completely in their specificity and the protein composition of the complex. Furthermore, If phosphorylation of serine residue 38 in the N-terminal sequence of wee1 is necessary for interacting with the APC is only active after metaphase and during G1, while many SCF ligases target substrates for degradaTome-1 and Tome-1 is required for degradation of wee1, one would anticipate that mutating this site would dration during the S or G2 phases of the cell cycle. A key SCF substrate degraded during the G2 phase matically affect the degradation rate of wee1. To test this hypothesis, we compared the ability of wild-type of the cell cycle is the wee1 tyrosine kinase. Wee1 levels decrease as cells enter G2, thereby allowing for cdk1 wee1 and S38A-wee1 to be degraded in Xenopus interphase egg extracts supplemented with sperm nuclei.
activation at the end of G2 (Michael and Newport, 1998). While wee1 degradation was not apparent in the early As shown in Figure 6D , the in vitro degradation rate of the S38A-wee1 mutant is much lower than the rate studies of the cell cycle in nucleus-free cytoplasmic extracts, recent studies have shown that it is important observed for wild-type wee1, indicating that phosphorylation at this site is critical for wee1 degradation. Consisin somatic cells and very likely in embryonic systems as well. Before M phase, wee1 remains in the nucleus, tent with this finding is the observation that injecting S38A-wee1 into dividing embryos inhibits mitotic entry possibly protecting the nucleus from cytoplasmically activated cdk1 (Heald et al., 1993) . Since cdk1/cyclin B ( Figure 6E ). This inhibition of mitotic entry is likely due to the fact that in vivo S38A-wee1 is turned over more protein levels would have reached a level capable of activating mitosis, even a slight reduction in the amount slowly than wild-type wee1 or a kinase inactive mutant of wee1 ( Figure 6F) . of wee1 would tip the balance in favor of active cdk1 and allow for nuclear envelope breakdown and mitotic These studies suggested that the state of phosphorylation may be regulated physiologically and serves as progression. We have identified the gene product Tome-1, which favors the active form of cdk1 by taran entry gate to mitotic progression. To test this idea, we measured the phosphorylation levels on serine 38 by geting wee1 for degradation. One of the most interesting features of this protein is that it is itself degraded, possia new mass spectrometry method that yields absolute quantitation of protein abundance and phosphorylation bly to insure that degradation of wee1 is transient and only occurs during G2. Perhaps even more interesting (Stemmann et al., 2002 ). This analysis indicated that the levels of wee1 phosphorylation depend on nuclei is that Tome-1 degradation is APC mediated, since it provides further evidence that the activities of ubiquiconcentration. We also found that the extent of wee1 phosphorylation at serine 38 decreases by 60% when tinylation machineries are interdependent during the cell cycle. the DNA replication checkpoint is induced in the presence of nuclei and aphidicolin (Figures 6G and 6H) . This was determined after mass spectrometric based quantiTome-1 Is a Substrate of the APC during G1 fication of wee1 isolated from interphase egg extracts, One of the striking characteristics of the cell cycle is egg extracts supplemented with nuclei, or egg extracts that protein degradation acts as a trigger at several supplemented with nuclei and aphidicolin. This analysis points to allow cell cycle transitions to occur. For examindicated that 48% of endogenous wee1 was phosphorple, the APC-mediated degradation of securin is reylated in egg extracts supplemented with nuclei, 24% quired for cells to proceed from metaphase to anaphase of wee1 was phosphorylated in egg extracts alone, and (Cohen-Fix et al., 1996), while the SCF-dependent deg-20% of wee1 was phosphorylated in the presence of radation of cyclin-dependent kinase inhibitors is renuclei and aphidicolin ( Figures 6G and 6H ). There was quired to promote S phase (Peters, 1998 tion. We think wee1 is likely to be the only critically important substrate during an embryonic cell cycle since removing wee1 overrides the mitotic entry defect observed when Tome-1 function is disrupted. Tome-1 might function during other phases of the cell cycle by mediating degradation of different substrates at different times. However, during an embryonic cell cycle there is no indication that Tome-1 has any other role in the cell cycle, since we see no effect on DNA replication in Xenopus egg extracts (N.G.A. and M.W.K., unpublished  data) . ciates with wee1 in a phosphospecific manner and that phosphorylation at this site is regulated during the cell
Experimental Procedures
CDH1 Substrate Screen
Degradation Assays
cycle. An alternative view that Tome-1 is a phosphoTome-1 degradation in Xenopus egg extracts was performed as specific inhibitor of wee1 has been eliminated by showpreviously described (Pfleger and Kirschner, 2000) . 100 M of ing that Tome-1 has no effect on wee1 activity (see In Vitro Binding Assays To assay association of Tome-1 with Skp-1, 5 g of Tome-1 or was added to interphase extracts in a 1:1 ratio while methyl-ubiquitin (Boston Biochem) was added to a final concentration of 10 mg/ml. ⌬N-Tome-1 was bound to 5 l of Glutathione beads and incubated in 100 l of 1 mg/ml ovalbumin in XB buffer. 10 l of in vitro transThe extent of wee1 poly-ubiquitinylation was measured by quantitating entire lanes after subtracting the signal generated from input lated, 35 S-labeled-Skp-1 was added to glutathione beads containing Tome-1 or GST alone for 1 hr at room temperature. The beads were wee1.
isolated by centrifugation and washed three times in XB (100 l), followed by one time in XB ϩ 0.3M NaCl. After a final wash in XB,
